Dr. Leena Cherukuri, MD

Dr. Cherukuri practices at Presbyterian Rust Medical Center in Rio Rancho, New Mexico.

Dr. Cherukuri's NPI, 1144369166, was assigned on February 6, 2007. Dr. Cherukuri holds New Mexico license MD 2008-0839.

Dr. Cherukuri's primary practice is Presbyterian Rust Medical Center, at 2400 Unser SE Blvd, Rio Rancho, NM 87124 in Sandoval County. The practice phone is (505) 253-6015.

Dr. Cherukuri's primary practice is Presbyterian Rust Medical Center in Rio Rancho, New Mexico. Dr. Cherukuri is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Cherukuri to 2 more hospitals, 3 medical groups, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cherukuri practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Cherukuri's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Cherukuri is licensed in New Mexico.

CMS data shows 281 Medicare services from Dr. Cherukuri across 5 procedure codes in 2024, for 239 Medicare patients. Medicare paid $10,204 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 239 Medicare patients who saw Dr. Cherukuri in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cherukuri's median patient age at 60, with 58% women.

In 2024, Dr. Cherukuri wrote 99 Medicare Part D claims for 21 patients. 39% of them were for generic drugs. CMS names the drug for 67 of them, across 3 drugs with 11 or more claims each, at $54,955 in total drug cost. In 2023, CMS named 162 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Cherukuri for performance year 2024, reported as part of a group. Dr. Cherukuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 14 general payments to Dr. Cherukuri from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $187.